Literature DB >> 32156326

Investigation of Various Intramuscular Volumes Delivered to the Semimembranosus Muscle of Cavia porcellus.

Michael A Bencivenga1, Philip A Bowling2, Jimmy O Fiallos2, Alicia M Gehling2, Robert G Stafford3, Simon Y Long4, David P Fetterer5, Thomas M Bocan3, Christian C Hofer2.   

Abstract

The goal of this study is to provide quantitative data on the ideal volume for intramuscular (IM) injections into the semimembranosus muscle of guinea pigs weighing between 320 to 410 grams. This evaluation comprised 2 experiments. The first was to assess dispersion leakage of intramuscularly injected iohexol, a radiocontrast agent commonly used in Computed Tomography (CT), based on analysis of in vivo imaging. The second used varying volumes of intramuscularly injected sodium chloride (0.9% NaCl) to assess pain and pathology associated with IM injection. Hartley guinea pigs were injected IM with varying volumes of either iohexol or sodium chloride (150, 300, 500, 1000 and 1500 μL). In the iohexol experiment, results suggest IM volumes of 150 and 300 μL remain within the target muscle. In the experiment using sodium chloride, pain and pathology did not increase as IM volume increased. The pathology noted was related to needle tract through the musculature rather than the volume size of the injectate. The results did not reveal a correlation between volume of IM 0.9% NaCl and pain levels. We conclude that volume size correlates more with precision and accuracy of delivery into the intended muscle tissue. Regarding tissue distribution, our findings also suggest that the optimal capacity for IM injection in the semimembranosus muscle should be less than 500 μL.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32156326      PMCID: PMC7210734          DOI: 10.30802/AALAS-JAALAS-19-000101

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  21 in total

1.  A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Authors:  K H Diehl; R Hull; D Morton; R Pfister; Y Rabemampianina; D Smith; J M Vidal; C van de Vorstenbosch
Journal:  J Appl Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.446

2.  Ethics and animal welfare related to in vivo pharmacology and toxicology in laboratory animals.

Authors:  Ove Svendsen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-10       Impact factor: 4.080

3.  Histopathological lesions following intramuscular administration of saline in laboratory rodents and rabbits.

Authors:  Celine Thuilliez; Laetitia Dorso; Paul Howroyd; Sarah Gould; Franck Chanut; Roger Burnett
Journal:  Exp Toxicol Pathol       Date:  2008-10-01

4.  Absorption of drugs from the skeletal muscle of the rats. 4. Absorption of cationic drugs from the muscle.

Authors:  K Okumura; H Sezaki; K Kakemi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1972-08       Impact factor: 1.645

5.  Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.

Authors:  J G Wagner
Journal:  Am J Pharm Sci Support Public Health       Date:  1969 Jan-Feb

6.  A new approach to intramuscular placement of horseradish peroxidase.

Authors:  K M Klueber; M Ontell
Journal:  Muscle Nerve       Date:  1984-02       Impact factor: 3.217

7.  Tissue response to intramuscular and intraperitoneal injections of ketamine and xylazine in rats.

Authors:  K L Smiler; S Stein; K L Hrapkiewicz; J R Hiben
Journal:  Lab Anim Sci       Date:  1990-01

8.  DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.

Authors:  Kathleen A Cashman; Eric R Wilkinson; Suzanne E Wollen; Joshua D Shamblin; Justine M Zelko; Jeremy J Bearss; Xiankun Zeng; Kate E Broderick; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2017-11-14       Impact factor: 3.452

9.  Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients.

Authors:  Emmanuelle Rouve; Karim Lakhal; Charlotte Salmon Gandonnière; Youenn Jouan; Laetitia Bodet-Contentin; Stephan Ehrmann
Journal:  BMC Nephrol       Date:  2018-11-06       Impact factor: 2.388

10.  Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures.

Authors:  Jessica Pingel; Mikkel Schou Nielsen; Torsten Lauridsen; Kristian Rix; Martin Bech; Tine Alkjaer; Ida Torp Andersen; Jens Bo Nielsen; R Feidenhansl
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.